According to this “cholinergic hypothesis”, the dysfunction of acetylcholine-containing neurons in the basal forebrain contributes significantly to the cognitive decline typical of AD, suggesting a potential therapeutic role of NGF in preserving the phenotype of these neurons [89]. This evidence concerns the gene NGF and Alzheimer disease.